Etanercept-induced cutaneous and pulmonary sarcoid-like granulomas resolving with adalimumab

Journal of Cutaneous Pathology

Volumn 39, Issue 2, 2012, Pages 289-293

  Burns, Ariel M ^a   Green, Peter J ^a   Pasternak, Sylvia ^b  

^a DALHOUSIE UNIVERSITY   (Canada)

^b QUEEN ELIZABETH II HEALTH SCIENCES CENTRE   (Canada)

Author keywords

Biologic therapy; Granulomatous inflammation; Sarcoidosis; Tumor necrosis factor alpha

Indexed keywords

ADALIMUMAB; ANTIRHEUMATIC AGENT; IMMUNOGLOBULIN G; MONOCLONAL ANTIBODY; TNFR FC FUSION PROTEIN; TNFR-FC FUSION PROTEIN; TUMOR NECROSIS FACTOR RECEPTOR;

ARTICLE; CASE REPORT; CHEMICALLY INDUCED DISORDER; FEMALE; HUMAN; LUNG GRANULOMA; MIDDLE AGED; PATHOLOGY; RHEUMATOID ARTHRITIS; SARCOIDOSIS; SKIN DISEASE;

ANTIBODIES, MONOCLONAL, HUMANIZED; ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; FEMALE; GRANULOMA, RESPIRATORY TRACT; HUMANS; IMMUNOGLOBULIN G; MIDDLE AGED; RECEPTORS, TUMOR NECROSIS FACTOR; SARCOIDOSIS, PULMONARY; SKIN DISEASES;

EID: 84859270666     PISSN: 03036987     EISSN: 16000560     Source Type: Journal    
DOI: 10.1111/j.1600-0560.2011.01795.x     Document Type: Article

References (13)

1. Moustou A.-E, Matekovits A, Dessinioti C, Antoniou C, Sfikakis PP, Statigos AJ. Cutaneous side effects of anti-tumor necrosis factor biologic therapy: a clinic review. J Am Acad Dermatol 2009; 61: 486.
2. Daïen CI, Monnier A, Claudepierre P, et al. Sarcoid-like granulomatosis in patients treated with tumor necrosis factor blockers: 10 cases. Rheumatology 2009; 48: 883.
3. Massara Am Cavazzini L, La Corte R, Trotta F. Sarcoidosis appearing during antitumor necrosis factor α therapy: a new "class effect" paradoxical phenomenon. Two case reports and literature review. Semin Arthritis Rheum 2010; 39: 313.
4. Marcoval J, Mañá J, Moreno A, Gallego I, Fortuño Y, Peyrí J. Foreign bodies in granulomatous cutaneous lesions of patients with systemic sarcoidosis. Arch Dermatol 2001; 137: 427.
5. Skoie IM, Wildhagen K, Omdal R. Development of sarcoidosis following etanercept treatment: a report of three cases. Rheumatol Int 2010 [Epub ahead of print].
6. Ishiguro T, Takayanagi N, Kurashima K, et al. Development of sarcoidosis during etanercept therapy. Intern Med 2008; 47: 1021.
7. Antoniu SA. Targeting the TNF-alpha pathway in sarcoidosis. Expert Opin Ther Targets 2010; 14: 21.
8. Utz JP, Limper AH,Kalra S, et al.Etanercept for the treatment of stage II and III progressive pulmonary sarcoidosis. Chest 2003; 124: 177.
9. CuchacovichR,Hagan J, TahirK,Richert A, Espinoza L. Tumor necrosis factor-alpha (TNF-α)-blockade-induce hepatic sarcoidosis in psoriatic arthritis (PsA): case report and review of the literature. Clin Rheumatol 2011; 30: 133.
10. Dhaille F, Viseux V, Caudron A, et al. Cutaneous sarcoidosis occurring during anti-TNFalpha treatment: report of two cases. Dermatology 2010; 220: 234.
11. Clementine RR, Lyman J, Zakem J, Mallepalli J, Lindsey S, Quinet R. Tumor necrosis factor-alpha antagonist-induced sarcoidosis. J Clin Rheumatol 2010; 16: 274.
12. Strober BE, Poulin Y, Kerdel FA, et al. Switching to adalimumab for psoriasis patients with a suboptimal response to etanercept, methotrexate, or phototherapy: Efficacy and safety results from an open-label study. J Am Acad Dermatol 2011; 64: 671.
13. North J, Mully T. Alpha-interferon induced sarcoidosis mimicking metastatic melanoma. J Cutan Pathol 2001; 38: 585.